ARVN(Arvinas, Inc.) · 财务报表

ARVN(Arvinas, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$53.60M$131.40M$78.50M$263.40M$262.60M
毛利润—————
营业利润−$188.40M−$263.20M−$401.50M−$250.20M−$118.50M
净利润−$191.00M−$282.50M−$367.30M−$198.90M−$80.80M
经营现金流$559.40M−$273.50M−$347.80M−$259.30M−$273.80M
自由现金流$554.70M−$280.30M−$350.70M−$261.10M−$275.70M
摊薄每股收益$-3.82$-5.31$-6.62$-2.77$-1.14

Arvinas, Inc. ARVN